EUVIMEDEUVIMED entdecken
Crossref

Seroprevalence of enterovirus D68 in Yamagata, Japan, between 1976 and 2019

Tsutomu Itagaki, Kenichi Komabayashi iD, Mika Sasaki, Naomi Ogawa, Junji Seto, Yoko Aoki, Tatsuya Ikeda, Yoko Matsuzaki iD, Katsumi Mizuta

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29947 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Tsutomu Itagaki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Yamanobe Pediatric Clinic, Yamagata, Japan. Hauptthemen laut MEDLINE: Enterovirus Infections, Enterovirus D, Human, Antibodies, Viral, Antibodies, Neutralizing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: The association for reserch on lactic acid bacteria, Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To clarify the epidemiology of enterovirus D68 (EV‐D68), an enterovirus rarely identified in the 20th century, we performed seroepidemiological analysis against EV‐D68 using sera collected in 1976, 1985, 1990, 1999, 2009, and 2019, as well as Yamagata isolate (EVD68/Yamagata.JPN/2023‐89), in Yamagata, Japan. The neutralizing antibody (Ab)‐positive rates for those under 20 years old were 61.0%, 82.5%, 84.3%, 46.7%, 50.5%, and 67.9%, in each year, whereas the rates for those above 20 years old were between 93.4% and 99.1%. Generally, geometric mean titers (GMTs)increased with age among children and the total GMT in each year was 25.4, 49.2, 37.2, 30.8, 29.5, and 33.9, from 1976 to 2019, respectively. The findings in this Yamagata‐based study showed that the seroprevalence of EV‐D68 over the last four decades has increased with age among children, as a susceptible group, and then reaches a plateau of over approximately 80% among adults. This study clearly revealed that EV‐D68 was stably transmitted among children in the 20th century, when EV‐D68 detection was quite rare.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterovirus InfectionsEnterovirus D, HumanAntibodies, ViralAntibodies, NeutralizingHumansSeroepidemiologic StudiesJapanChildChild, PreschoolAdolescentYoung AdultAdultInfantFemaleMaleMiddle AgedAgedAged, 80 and over

Stichwörter der Autor:innen

acute respiratory infectionenterovirus D68epidemiologyseroepidemiology

Substanzen

Antibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Yamanobe Pediatric Clinic, Yamagata, Japan.
  • Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, Japan.
  • Department of Infectious Diseases, Yamagata University Faculty of Medicine, Yamagata, Japan.

ORCID-Profile: Kenichi Komabayashi, Yoko Matsuzaki

Förderung

  • The association for reserch on lactic acid bacteria, Japan

Zitieren

APA

Itagaki, T., Komabayashi, K., Sasaki, M., Ogawa, N., Seto, J., Aoki, Y., Ikeda, T., Matsuzaki, Y., & Mizuta, K. (2024). Seroprevalence of enterovirus D68 in Yamagata, Japan, between 1976 and 2019. Journal of Medical Virology. https://doi.org/10.1002/jmv.29947

Vancouver

Itagaki T, Komabayashi K, Sasaki M, Ogawa N, Seto J, Aoki Y, et al. Seroprevalence of enterovirus D68 in Yamagata, Japan, between 1976 and 2019. Journal of Medical Virology. 2024. doi:10.1002/jmv.29947

BibTeX
@article{Itagaki2024,
  author = {Itagaki, Tsutomu and Komabayashi, Kenichi and Sasaki, Mika and Ogawa, Naomi and Seto, Junji and Aoki, Yoko and Ikeda, Tatsuya and Matsuzaki, Yoko and Mizuta, Katsumi},
  title = {Seroprevalence of enterovirus D68 in Yamagata, Japan, between 1976 and 2019},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29947}
}
Kostenlos starten →